Caracterização físico-química, modelagem molecular e investigação da ação da lectina CRLII em processos inflamatórios e do potencial antitumoral das lectinas CRLI e CRLII

Abstract

Lectins are proteins of non-immune origin that have at least one non-catalytic site capable of recognizing carbohydrates in a specific and reversible manner without altering the structure of these molecules. These proteins are widely distributed in nature being found in microorganisms, invertebrate and vertebrate animals and in plants. In vegetables, lectins may be present in roots, stems, leaves, fruits and in seeds, where they are generally expressed in higher concentration. The most studied vegetable lectins are those found in the legume family in which is worth mentioning the subtribe Diocleineae, whose lectins present a peculiar post-translational processing, is characterized by an alpha chain formed by the junction and inversion of the beta and gamma fragments. The literature reports many biotechnological applications for different plant lectins, for example antimicrobial activity, antidepressive, pro and anti-inflammatory, induction of proliferation and cell death, anticancer activity among others. It is important to note that, although lectins are extremely structurally related, they behave very differently when compared in terms of potency in the evaluation of a given biological activity. In this way, investigating new lectins and their biotechnological potential is of enormous value in the discovery of new tools that can be used in different biological models, in the diagnosis and/or therapeutics in the various diseases that afflict human, vegetal and animal health. In this context, this work aimed to characterize physicochemically, to determine the three-dimensional structure and to evaluate the proinflammatory, anti-inflammatory and antiglioma activities of the specific lectin lactose Cymbosema roseum (CRLII), as well as to evaluate the antiglioma activity of the lectin specific mannose of Cymbosema roseum (CRLI) isolated from this plant seeds. CRLII presented optimum hemagglutinating activity (A.H.) in buffer solution with pH between 6 and 8, thermostability up to 40 ° C and the three-dimensional modeled structure presented similarity with the lectin from Vatairea macrocarpa (VML). Regarding the biotechnological potential in inflammation, CRLII showed anti-inflammatory activity via carbohydrate recognition domain (CRD) showing greater effect in the fourth hour. CRLII did not present pro-inflammatory activity. In tests on C6 lineage of Rattus norvegicus glioma cells, CRLII showed no ability to reduce viability, migration or cause changes in morphology and physiology in the cells tested, unlike CRLI which reduced the viability and migration of C6 lineage of Rattus norvegicus glioma cells line evidencing necrosis and apoptosis as mechanisms of cell death. New investigations must be carried out in order to better explain these effects and to establish structure / function correlations.